Johnson & Johnson Covid-19 vaccine is 66% effective in global trial, but 85% effective against severe disease, company says ...Middle East

Los Angeles Daily News - News
Johnson & Johnson Covid-19 vaccine is 66% effective in global trial, but 85% effective against severe disease, company says
It's a striking difference from vaccines from Pfizer/BioNTech and Moderna, and it may give pause to people uncertain about which vaccine to get or when they can get one.

Read More Details
Finally We wish PressBee provided you with enough information of ( Johnson & Johnson Covid-19 vaccine is 66% effective in global trial, but 85% effective against severe disease, company says )

Apple Storegoogle play

Also on site :



Latest News